ADVANCED IMAGING AND MULTIMODAL MONITORING OF JOINT AND SYSTEMIC DAMAGE IN POST-COVID RHEUMATIC DISEASES

The assessment of joint and systemic involvement in rheumatic diseases has traditionally relied on clinical examination and conventional laboratory markers. However, the post-COVID-19 landscape has revealed limitations in these approaches, as persistent subclinical inflammation, endothelial dysfunction, and fibrotic progression often precede overt clinical deterioration